The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Next Generation Biomanufacturing Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Competitors & Product Analysis 4.3. Regulatory Framework 4.4. Company market share analysis, 2019 4.5. Porter's Five forces analysis 4.6. New Investment Analysis 4.7. PESTEL Analysis 5. Global Next Generation Biomanufacturing Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Work flow and Product 5.2.1.1. Continuous Upstream Biomanufacturing 5.2.1.1.1. Bioreactors/Fermenters 5.2.1.1.2. Cell Culture Products 5.2.1.1.3. Filtration Systems 5.2.1.1.4. Bags & Containers 5.2.1.1.5. Mixing System 5.2.1.1.6. Sterilizers 5.2.1.1.7. Biosafety Cabinets 5.2.1.1.8. Incubators 5.2.1.1.9. Others 5.2.1.2. Single-Use Upstream Biomanufacturing 5.2.1.2.1. Single-Use Bioreactors 5.2.1.2.2. Single-Use Bags and Containers 5.2.1.2.3. Single-Use Tubing and Connectors 5.2.1.2.4. Single-Use Mixing Systems 5.2.1.2.5. Single-Use Sensors and Probes 5.2.1.3. Downstream Biomanufacturing 5.2.1.3.1. Chromatography Systems 5.2.1.3.2. Filtration Systems 5.2.1.3.3. Membrane Absorbers 5.2.1.3.4. Instruments and Accessories 5.2.1.3.5. Single-Use Equipment and Accessories 5.2.2. By Medical Application 5.2.2.1. Monoclonal Antibodies 5.2.2.2. Hormones 5.2.2.3. Vaccines 5.2.2.4. Recombinant Proteins 5.2.2.5. Others 5.2.3. By End-user 5.2.3.1. Commercial Stage 5.2.3.2. Preclinical and Development Stage 5.2.4. By Region 5.2.4.1. Europe 5.2.4.2. North America 5.2.4.3. Asia Pacific 5.2.4.4. South America 5.2.4.5. Middle East & Africa 6. Europe Next Generation Biomanufacturing Market Overview 6.1. Europe Next Generation Biomanufacturing Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. Europe Next Generation Biomanufacturing Market Share & Forecast, 2016-2027 6.2.1. By Work flow and Product 6.2.1.1. Continuous Upstream Biomanufacturing 6.2.1.1.1. Bioreactors/Fermenters 6.2.1.1.2. Cell Culture Products 6.2.1.1.3. Filtration Systems 6.2.1.1.4. Bags & Containers 6.2.1.1.5. Mixing System 6.2.1.1.6. Sterilizers 6.2.1.1.7. Biosafety Cabinets 6.2.1.1.8. Incubators 6.2.1.1.9. Others 6.2.1.2. Single-Use Upstream Biomanufacturing 6.2.1.2.1. Single-Use Bioreactors 6.2.1.2.2. Single-Use Bags and Containers 6.2.1.2.3. Single-Use Tubing and Connectors 6.2.1.2.4. Single-Use Mixing Systems 6.2.1.2.5. Single-Use Sensors and Probes 6.2.1.3. Downstream Biomanufacturing 6.2.1.3.1. Chromatography Systems 6.2.1.3.2. Filtration Systems 6.2.1.3.3. Membrane Absorbers 6.2.1.3.4. Instruments and Accessories 6.2.1.3.5. Single-Use Equipment and Accessories 6.2.2. By Medical Application 6.2.2.1. Monoclonal Antibodies 6.2.2.2. Hormones 6.2.2.3. Vaccines 6.2.2.4. Recombinant Proteins 6.2.2.5. Others 6.2.3. By End-user 6.2.3.1. Commercial Stage 6.2.3.2. Preclinical and Development Stage 6.2.4. By Country 6.2.4.1. Germany 6.2.4.2. UK 6.2.4.3. France 6.2.4.4. Italy 6.2.4.5. Rest of Europe 6.2.5. Company Market Share (Top 3-5) 6.2.6. Economic Impact Study on Europe Next Generation Biomanufacturing Market 7. North America Next Generation Biomanufacturing Market Overview 7.1. North America Next Generation Biomanufacturing Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. North America Next Generation Biomanufacturing Market Share & Forecast, 2016-2027 7.2.1. By Work flow and Product 7.2.1.1. Continuous Upstream Biomanufacturing 7.2.1.1.1. Bioreactors/Fermenters 7.2.1.1.2. Cell Culture Products 7.2.1.1.3. Filtration Systems 7.2.1.1.4. Bags & Containers 7.2.1.1.5. Mixing System 7.2.1.1.6. Sterilizers 7.2.1.1.7. Biosafety Cabinets 7.2.1.1.8. Incubators 7.2.1.1.9. Others 7.2.1.2. Single-Use Upstream Biomanufacturing 7.2.1.2.1. Single-Use Bioreactors 7.2.1.2.2. Single-Use Bags and Containers 7.2.1.2.3. Single-Use Tubing and Connectors 7.2.1.2.4. Single-Use Mixing Systems 7.2.1.2.5. Single-Use Sensors and Probes 7.2.1.3. Downstream Biomanufacturing 7.2.1.3.1. Chromatography Systems 7.2.1.3.2. Filtration Systems 7.2.1.3.3. Membrane Absorbers 7.2.1.3.4. Instruments and Accessories 7.2.1.3.5. Single-Use Equipment and Accessories 7.2.2. By Medical Application 7.2.2.1. Monoclonal Antibodies 7.2.2.2. Hormones 7.2.2.3. Vaccines 7.2.2.4. Recombinant Proteins 7.2.2.5. Others 7.2.3. By End-user 7.2.3.1. Commercial Stage 7.2.3.2. Preclinical and Development Stage 7.2.4. By Country 7.2.4.1. US 7.2.4.2. Canada 7.2.4.3. Mexico 7.2.5. Company Market Share (Top 3-5) 7.2.6. Economic Impact Study on North America Next Generation Biomanufacturing Market 8. Asia Pacific Next Generation Biomanufacturing Overview 8.1. Asia Pacific Next Generation Biomanufacturing Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific Next Generation Biomanufacturing Market Share & Forecast, 2016-2027 8.2.1. By Work flow and Product 8.2.1.1. Continuous Upstream Biomanufacturing 8.2.1.1.1. Bioreactors/Fermenters 8.2.1.1.2. Cell Culture Products 8.2.1.1.3. Filtration Systems 8.2.1.1.4. Bags & Containers 8.2.1.1.5. Mixing System 8.2.1.1.6. Sterilizers 8.2.1.1.7. Biosafety Cabinets 8.2.1.1.8. Incubators 8.2.1.1.9. Others 8.2.1.2. Single-Use Upstream Biomanufacturing 8.2.1.2.1. Single-Use Bioreactors 8.2.1.2.2. Single-Use Bags and Containers 8.2.1.2.3. Single-Use Tubing and Connectors 8.2.1.2.4. Single-Use Mixing Systems 8.2.1.2.5. Single-Use Sensors and Probes 8.2.1.3. Downstream Biomanufacturing 8.2.1.3.1. Chromatography Systems 8.2.1.3.2. Filtration Systems 8.2.1.3.3. Membrane Absorbers 8.2.1.3.4. Instruments and Accessories 8.2.1.3.5. Single-Use Equipment and Accessories 8.2.2. By Medical Application 8.2.2.1. Monoclonal Antibodies 8.2.2.2. Hormones 8.2.2.3. Vaccines 8.2.2.4. Recombinant Proteins 8.2.2.5. Others 8.2.3. By End-user 8.2.3.1. Commercial Stage 8.2.3.2. Preclinical and Development Stage 8.2.4. By Country 8.2.4.1. China 8.2.4.2. India 8.2.4.3. Japan 8.2.4.4. Australia 8.2.4.5. Rest of Asia Pacific 8.2.5. Company Market Share (Top 3-5) 8.2.6. Economic Impact Study on Asia Pacific Next Generation Biomanufacturing Market 9. South America Next Generation Biomanufacturing Market Overview 9.1. South America Next Generation Biomanufacturing Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America Next Generation Biomanufacturing Market Share & Forecast, 2016-2027 9.2.1. By Work flow and Product 9.2.1.1. Continuous Upstream Biomanufacturing 9.2.1.1.1. Bioreactors/Fermenters 9.2.1.1.2. Cell Culture Products 9.2.1.1.3. Filtration Systems 9.2.1.1.4. Bags & Containers 9.2.1.1.5. Mixing System 9.2.1.1.6. Sterilizers 9.2.1.1.7. Biosafety Cabinets 9.2.1.1.8. Incubators 9.2.1.1.9. Others 9.2.1.2. Single-Use Upstream Biomanufacturing 9.2.1.2.1. Single-Use Bioreactors 9.2.1.2.2. Single-Use Bags and Containers 9.2.1.2.3. Single-Use Tubing and Connectors 9.2.1.2.4. Single-Use Mixing Systems 9.2.1.2.5. Single-Use Sensors and Probes 9.2.1.3. Downstream Biomanufacturing 9.2.1.3.1. Chromatography Systems 9.2.1.3.2. Filtration Systems 9.2.1.3.3. Membrane Absorbers 9.2.1.3.4. Instruments and Accessories 9.2.1.3.5. Single-Use Equipment and Accessories 9.2.2. By Medical Application 9.2.2.1. Monoclonal Antibodies 9.2.2.2. Hormones 9.2.2.3. Vaccines 9.2.2.4. Recombinant Proteins 9.2.2.5. Others 9.2.3. By End-user 9.2.3.1. Commercial Stage 9.2.3.2. Preclinical and Development Stage 9.2.4. By Country 9.2.4.1. Brazil 9.2.4.2. Argentina 9.2.4.3. Rest of South America 9.2.5. Company Market Share (Top 3-5) 9.2.6. Economic Impact Study on South America Next Generation Biomanufacturing Market 10. Middle East & Africa Next Generation Biomanufacturing Market Overview 10.1. Middle East & Africa Next Generation Biomanufacturing Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa Next Generation Biomanufacturing Market Share & Forecast, 2016-2027 10.2.1. By Work flow and Product 10.2.1.1. Continuous Upstream Biomanufacturing 10.2.1.1.1. Bioreactors/Fermenters 10.2.1.1.2. Cell Culture Products 10.2.1.1.3. Filtration Systems 10.2.1.1.4. Bags & Containers 10.2.1.1.5. Mixing System 10.2.1.1.6. Sterilizers 10.2.1.1.7. Biosafety Cabinets 10.2.1.1.8. Incubators 10.2.1.1.9. Others 10.2.1.2. Single-Use Upstream Biomanufacturing 10.2.1.2.1. Single-Use Bioreactors 10.2.1.2.2. Single-Use Bags and Containers 10.2.1.2.3. Single-Use Tubing and Connectors 10.2.1.2.4. Single-Use Mixing Systems 10.2.1.2.5. Single-Use Sensors and Probes 10.2.1.3. Downstream Biomanufacturing 10.2.1.3.1. Chromatography Systems 10.2.1.3.2. Filtration Systems 10.2.1.3.3. Membrane Absorbers 10.2.1.3.4. Instruments and Accessories 10.2.1.3.5. Single-Use Equipment and Accessories 10.2.2. By Medical Application 10.2.2.1. Monoclonal Antibodies 10.2.2.2. Hormones 10.2.2.3. Vaccines 10.2.2.4. Recombinant Proteins 10.2.2.5. Others 10.2.3. By End-user 10.2.3.1. Commercial Stage 10.2.3.2. Preclinical and Development Stage 10.2.4. By Country 10.2.4.1. Saudi Arabia 10.2.4.2. UAE 10.2.4.3. South Africa 10.2.4.4. Rest of Middle East & Africa 10.2.5. Company Market Share (Top 3-5) 10.2.6. Economic Impact Study on Middle East & Africa Next Generation Biomanufacturing Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1. Merck KGaA 11.7.2. Thermo Fisher Scientific Inc. 11.7.3. Danaher Corporation 11.7.4. Eppendorf AG 11.7.5. Sartorius AG 11.7.6. GEA Group Aktiengesellschaft 11.7.7. bbi-biotech GmbH 11.7.8. Esco Group of Companies 11.7.9. Pierre Guérin 11.7.10. Solaris Biotechnology Srl. 11.7.11. PBS Biotech, Inc. 11.7.12. ZETA GmbH 11.7.13. Applikon Biotechnology BV 11.7.14. Meissner Filtration Products, Inc. 11.7.15. Shanghai Bailun Biotechnology Co. Ltd. 11.7.16. Others prominent player.
Price : US$ 3,500 | Date : Nov 2024 |
Category : Manufacturing and Construction | Pages : 122 |
Price : US$ 3,500 | Date : Nov 2024 |
Category : Services | Pages : 101 |
Price : US$ 3,500 | Date : Nov 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 123 |
Price : US$ 3,500 | Date : Oct 2024 |
Category : Services | Pages : 139 |
Price : US$ 3,500 | Date : Oct 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 115 |
We will be happy to help you find what you need. Please call us or write to us: